Evidence map›Paper›PMID 41326758›Full record

ArticleScientific reports2025

Co-occurrence of mcr-1 and mcr-3 mobilized colistin resistance genes among carbapenem-resistant Pseudomonas aeruginosa in Iran.

Neda Razavi Davoodi, Neda Soleimani, Seyed Masoud Hosseini, Marjan Rahnamaye-Farzami

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Neda Razavi DavoodiDepartment of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
Neda SoleimaniDepartment of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. N_soleimani@sbu.ac.ir.ORCID http://orcid.org/0000-0003-0803-9818
Seyed Masoud HosseiniDepartment of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
Marjan Rahnamaye-FarzamiDepartment of Microbiology, Reference Health Laboratory Research Center, Ministry of Health and Medical Education Tehran, No. 48, Kaikhosrov Shahrokh Alley, Zartoshtian St, Hafez Avenue, Tehran, Iran. marjan.farzami@gmail.com.ORCID http://orcid.org/0000-0001-9745-1657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenemase-producing Pseudomonas aeruginosa (CRPA) poses a significant challenge to the effectiveness of antimicrobial therapy in patients, further complicated by the emergence of colistin resistance (CLR). This study aimed to provide molecular epidemiological insights into clinical P. aeruginosa strains that produce carbapenemases and exhibit CLR. A total of fifty clinical isolates of CRPA were collected from Milad Hospital in Tehran, Iran. Antimicrobial susceptibility testing and colistin broth disk elution were performed to determine the resistance patterns. PCR assays were conducted to investigate the prevalence of resistance-associated genes, including bla

Indexed as

Bacterial ProteinsCarbapenemsColistinDrug Resistance, BacterialPseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial Agentsbeta-LactamasesHumansIranMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsColistinCarbapenemasesColistinMcr genesP. aeruginosaPFGE

Identifiers

PMID41326758
PMCPMC12780099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.